A survey of surgeons revealed that specialists are decreasing the use of transvaginal mesh to repair pelvic organ prolapse. The survey was conducted to determine if a recent transvaginal mesh warning issued by the Food and Drug Administration (FDA) had any effect on use of the products.
The FDA issued a mesh warning after receiving an influx of complaints from patients who allege that their transvaginal mesh device were causing severe complications, pain and sometimes revision surgery. More than 23% of the specialists surveyed said they would decrease use of mesh because of these results, and more than 53% said they would provide patients with more information about the mesh.
Many surgical mesh manufacturers, including Johnson & Johnson and Bard, have voluntarily recalled transvaginal mesh products after increased patient complaints. Some companies have set aside money to settle transvaginal mesh lawsuits filed by patients who allege the devices failed.